High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes

被引:61
|
作者
Di Pino, A. [1 ]
Currenti, W. [1 ]
Urbano, F. [1 ]
Scicali, R. [1 ]
Piro, S. [1 ]
Purrello, F. [1 ]
Rabuazzo, A. M. [1 ]
机构
[1] Univ Catania, Dept Clin & Expt Med, Catania, Italy
关键词
Type; 2; diabetes; Dietary advanced glycation end-products; Cardiovascular disease; Soluble receptor for advanced glycation endproducts; Inflammation; CORONARY-HEART-DISEASE; SOLUBLE RECEPTOR; OXIDATIVE STRESS; GLYCOXIDATION; GLYCOTOXINS; RISK; MORTALITY;
D O I
10.1016/j.numecd.2017.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk. In this cross-sectional study we investigate the relationship between dAGE intake, arterial stiffness, inflammatory profile and macronutrient composition, in subjects with type 2 diabetes without overt cardiovascular disease. Methods and results: Arterial stiffness, carboxy-methyl-lysine, endogenous secretory receptor for AGEs (esRAGE), high sensitivity C reactive protein (hs-CRP), S100A12 and macronutrient intake were evaluated in 85 subjects with type 2 diabetes. The subjects were stratified into two groups according to dAGE consumption: high and low dAGE intake (>= or < 15.000 kU/day, respectively). Subjects with high dAGE intake (n = 45) showed a higher augmentation, augmentation index and pulse wave velocity (PWV) compared with those subjects with low dAGE intake (18 +/- 5.4 vs 12.2 +/- 6.3 mmHg, P < 0.05; 38.3 +/- 5.4 vs 29.3 +/- 10%; 9.2 +/- 1.4 m/sec vs 7.9 +/- 1.7, P < 0.05, respectively). hs-CRP were higher in subjects with high dAGE intake [0.42 (0.18 -.54) vs 0.21 (0.14-.52) mg/dL, P < 0.05] whereas esRAGE plasma levels were lower [0.16 (0.23-.81) vs 0.2 (0.14-.54) ng/dL, P < 0.05]. Simple regression analysis showed a correlation between dAGEs and fat intake. Multivariate analysis showed an independent association between augmentation, systolic blood pressure (BP) and dAGE consumption; BMI and esRAGE were the major determinants of PWV. Conclusions: Our data suggests that a chronic high dAGE diet could lead to a vascular dysfunction and inflammatory activation, contributing to the development of vascular complications in subjects with type 2 diabetes. Testing this hypothesis may represent a direction of future research. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:978 / 984
页数:7
相关论文
共 50 条
  • [21] Advanced glycation end-products and arterial stiffness in patients with diabetic nephropathy and patients with chronic kidney disease without diabetes
    Strozecki, Pawel
    Kurowski, Robert
    Flisinski, Mariusz
    Stefanska, Anna
    Odrowaz-Sypniewska, Grazyna
    Manitius, Jacek
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (11): : 609 - 616
  • [22] Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
    Mori, Hiroyasu
    Kuroda, Akio
    Ishizu, Masashi
    Ohishi, Mami
    Takashi, Yuichi
    Otsuka, Yinhua
    Taniguchi, Satoshi
    Tamaki, Motoyuki
    Kurahashi, Kiyoe
    Yoshida, Sumiko
    Endo, Itsuro
    Aihara, Ken-ichi
    Funaki, Makoto
    Akehi, Yuko
    Matsuhisa, Munehide
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (05) : 1332 - 1340
  • [23] Dietary Intake of Fat, Animal Products and Advanced Glycation End-Products and the Risk of Barrett's Esophagus
    Jiao, Li
    Chen, Liang
    Kramer, Jennifer R.
    Rugge, Massimo
    Parente, Paola
    Verstovsek, Gordana
    Alsarraj, Abeer
    El-Serag, Hashem
    GASTROENTEROLOGY, 2013, 144 (05) : S690 - S690
  • [24] Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes
    Tam, H. L.
    Shiu, S. W. M.
    Wong, Y.
    Chow, W. S.
    Betteridge, D. J.
    Tan, K. C. B.
    ATHEROSCLEROSIS, 2010, 209 (01) : 173 - 177
  • [25] Type 2 Diabetes Affects Advanced Glycation End-Products and Indentation Properties in Human Bone
    Rezaee, Taraneh
    Vaidya, Rachana
    Barret, Leland O.
    Silva, Zackery Joseph
    Ray, Christian Leonarde
    DeSimone, Brooke Lynn
    Karim, Lamya
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 257 - 258
  • [26] Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
    Tan, K. C. B.
    Chow, W. S.
    Tso, A. W. K.
    Xu, A.
    Tse, H. F.
    Hoo, R. L. C.
    Betteridge, D. J.
    Lam, K. S. L.
    DIABETOLOGIA, 2007, 50 (09) : 1819 - 1825
  • [27] Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
    K. C. B. Tan
    W. S. Chow
    A. W. K. Tso
    A. Xu
    H. F. Tse
    R. L. C. Hoo
    D. J. Betteridge
    K. S. L. Lam
    Diabetologia, 2007, 50 : 1819 - 1825
  • [28] Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes
    Singh, Indumathi
    Issar, Tushar
    Poynten, Ann M.
    Milner, Kerry-Lee
    Krishnan, Arun V.
    Dhanapalaratnam, Roshan
    BIOMEDICINES, 2024, 12 (11)
  • [29] Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
    Zawada, Agnieszka
    Machowiak, Alicja
    Rychter, Anna Maria
    Ratajczak, Alicja Ewa
    Szymczak-Tomczak, Aleksandra
    Dobrowolska, Agnieszka
    Krela-Kazmierczak, Iwona
    NUTRIENTS, 2022, 14 (19)
  • [30] ADVANCED GLYCATION END-PRODUCTS ARE ASSOCIATED WITH BETA(2)-MICROGLOBULIN AMYLOIDOSIS
    MIYAZAKI, S
    NIWA, T
    MORITA, T
    KODA, Y
    YUASA, Y
    SAKAI, S
    SUZUKI, M
    TAKAHASHI, S
    HIRASAWA, Y
    AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (06) : 535 - 536